Rashmi Patel, MD
Urology · Gahanna, OHNPI 1295775930
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,362 of the $6,458 with a category attached, or 67.6%. 31 manufacturers reported payments, led by Angiodynamics, Inc. at 42.8% of the total. Reporting peaked in 2023 at $2,769 and has fallen 61.8% since, to $1,058 in 2025.
Across 101 payments — averaging $63.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$3K
- EDAP Technomed Inc$575
- Myriad Genetic Laboratories, Inc.$515
- Progenics Pharmaceuticals, Inc.$447
- Teleflex LLC$297
- Laborie Medical Technologies Corp.$268
- plus $2K from 25 others
Across 2 payments — averaging $52,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Conmed Corporation$105K
What the payments were for
- Travel & lodging$2,09532%
- Food & beverage$4,36268%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 12 | $2,764 |
| EDAP Technomed Inc | 5 | $575 |
| Myriad Genetic Laboratories, Inc. | 13 | $515 |
| Progenics Pharmaceuticals, Inc. | 7 | $447 |
| Teleflex LLC | 3 | $297 |
| Laborie Medical Technologies Corp. | 9 | $268 |
| Boston Scientific | 3 | $232 |
| Olympus America Inc. | 4 | $199 |
| Sanofi | 3 | $173 |
| Conmed Corporation | 1 | $143 |
| AbbVie(2 entities) | 5 | $93 |
| Astellas Pharma US Inc | 6 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Myovant Sciences Inc. | 3 | $71 |
| Urogen Pharma, Inc. | 3 | $71 |
| Neotract Inc. | 2 | $53 |
| Dendreon Pharmaceuticals LLC | 2 | $49 |
| Coloplast | 3 | $47 |
| Profound Medical Corp. | 1 | $39 |
| Convatec Inc. | 1 | $37 |
| Theratechnologies Inc. | 1 | $35 |
| Bayer | 1 | $30 |
| Tolmar, Inc. | 1 | $23 |
| Pfizer | 1 | $19 |
| Palette Life Sciences, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Amgen | 1 | $15 |
| BD | 1 | $12 |
| Intuitive Surgical | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nanoknife$2,640
- FOCAL ONE$509
- PYLARIFY$286
- UroLift System$283
- iTIND System$150
- Prolaris$147
- AIRSEAL$143
- JEVTANA$128
- REZUM$119
How this compares
$6,458 in reported general payments places this provider in the 70th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 293 | $5,708 |
| Silodosin | 14 | $3,064 |
| Potassium Citrate ErPotassium Citrate | 35 | $2,506 |
| Finasteride | 86 | $1,652 |
| Methenamine Hippurate | 13 | $603 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $518 |
| Ciprofloxacin Hcl | 199 | $371 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $324 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 27 | $258 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $198 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $135 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 73 | $123 |
| Cephalexin | 30 | $95 |
| Gabapentin | 28 | $22 |
Paid to pharmacies, not to this prescriber.
Other urology in Gahanna
- Benjamin MartinGahanna$205K
- Lawrence GervasiMiddleburg Heights$1.1M
- Howard GoldmanCleveland$721K
- Ronney AbazaWorthington$374K
- Sriharan SivalingamCleveland$276K
- Sandip VasavadaCleveland$263K
- Jihad KaoukCleveland$234K
- Ruben OlivaresCleveland$184K
- Abhinav SidanaCincinnati$174K
- Raymond RackleyCleveland$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.